WHG
GSK icon

Westwood Holdings Group’s GSK GSK Stock Holding History

Westwood Holdings Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,875
Closed -$110K – 449
2019
Q4 		$110K Hold
1,875
– – ﹤0.01% 480
2019
Q3 		$100K Sell
1,875
-622
-25% -$32K ﹤0.01% 440
2019
Q2 		$125K Buy
+2,497
New +$125K ﹤0.01% 471
2017
Q4 		– Sell
-2,176
Closed -$110K – 418
2017
Q3 		$110K Sell
2,176
-44
-2% -$2.23K ﹤0.01% 393
2017
Q2 		$120K Sell
2,220
-140
-6% -$7.46K ﹤0.01% 417
2017
Q1 		$124K Buy
2,360
+320
+16% +$16.2K ﹤0.01% 384
2016
Q4 		$98K Hold
2,040
– – ﹤0.01% 433
2016
Q3 		$110K Buy
+2,040
New +$112K ﹤0.01% 433
2015
Q2 		– Sell
-161,915
Closed -$9.34M – 362
2015
Q1 		$9.34M Buy
161,915
+15,539
+11% +$891K 0.07% 171
2014
Q4 		$7.82M Sell
146,376
-11,438
-7% -$640K 0.06% 191
2014
Q3 		$9.07M Sell
157,814
-1,404,962
-90% -$86.1M 0.07% 182
2014
Q2 		$104M Sell
1,562,776
-40,609
-3% -$2.75M 0.77% 46
2014
Q1 		$107M Sell
1,603,385
-115,801
-7% -$7.83M 0.82% 45
2013
Q4 		$115M Buy
1,719,186
+1,644,426
+2,200% +$107M 0.88% 45
2013
Q3 		$4.69M Sell
74,760
-1,920
-3% -$124K 0.04% 209
2013
Q2 		$4.79M Buy
+76,680
New +$4.87M 0.04% 215

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Westwood Holdings Group's GSK Position: Q1 2020 in Review

Westwood Holdings Group sold out of GSK (GSK) in Q1 2020, closing a stake of 1,875 shares — an estimated $110K sold.

Westwood Holdings Group first reported a position in GSK in Q2 2013 and held it in 16 quarters. The position peaked at $115M in Q4 2013. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Westwood Holdings Group reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Westwood Holdings Group sold 1,875 GSK shares in Q1 2020, an estimated $110K.
  • Westwood Holdings Group first reported a position in GSK in Q2 2013 and held it in 16 quarters.
  • Westwood Holdings Group's GSK position peaked at $115M in Q4 2013.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Westwood Holdings Group's 13F filing for Q1 2020, filed 15 May 2020.